Clarus — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
BiotechCambridge, US
Jill C. Milne(Executive Officer, Director)Ian Sanderson(Executive Officer)
BoardRon Laufer(Director)Jean George(Director)Michael Ross(Director)
Board seatNicholas Galakatos· per SEC Form D · $20.4M raise · filed Mar 2015
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)
Board seatEmmett CunninghamEmmett Cunningham, Jr.· per SEC Form D · $26M raise · filed Aug 2017
Co-investorsAPERTURE Venture PartnersEssex Woodlands Healthcare PartnersLongitude CapitalHealthQuest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.